The Engine Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Foray Bioscience uses single plant cells and AI-powered software (Pando) to direct how plant matter forms, producing plant materials, molecules, and seeds without growing whole plants.
AgTechAI & Machine LearningBiotechCambridge, US
Ashley Beckwith(Founder & CEO)in
Co-investorsCollaborative FundService Provider CapitalReGen VenturesTet Ventures
Kano Therapeutics develops circular single-stranded DNA (cssDNA) as a genetic payload for gene-editing and other DNA-based therapies, offering an alternative to viral vectors and double-stranded DNA.
BiotechDeep TechCambridge, US
Floris Engelhardt(Executive Officer, Director)John Vroom(Director)
BoardAnn DeWitt(Director)in
Co-investorsFifty YearsLaunchpad Venture GroupMetaplanetVsquared VenturesZAKA VC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








